Company: DAWN
Filing Date: 2025-11-13
Form Type: 8-K
Source: 0001104659-25-110812
Chunk: 1

Company: Day One Biopharmaceuticals, Inc.
Filing Date: 2025-11-13
Form: 8-K
Item: Item 9.01
Chunk 1
---
Item 9.01      Financial Statements and Exhibits.  

  (d)      Exhibits.  

  Exhibit      Description                                                                                                                                                                                           
   Number                                                                                                                                                                                                            
     2.1*      Agreement and Plan of Merger, dated November 12, 2025, by and among Parent, Merger Sub and Target (incorporated herein by reference to Exhibit 2.1 of Target’s Current Report on Form 8-K filed o...  
     10.1      Form of Tender and Support Agreement (incorporated herein by reference to Exhibit 2.2 of Target’s Current Report on Form 8-K filed on November 13, 2025).                                             
     10.2      Form of Contingent Value Rights Agreement (incorporated herein by reference to Exhibit 2.3 of Target’s Current Report on Form 8-K filed on November 13, 2025).                                        
     99.1      Press Release, dated November 13, 2025.                                                                                                                                                               
 ─────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────────
     99.2      Investor Presentation                                                                                                                                                                                 
     99.3      Corporate Presentation                                                                                                                                                                                
      104      Cover Page Interactive Data File (embedded within the Inline XBRL document).                                                                                                                          

*Certain
annexes, exhibits and schedules have been omitted pursuant to Item 601(a)(5) of Regulation S-K. The registrant hereby undertakes to furnish
supplemental copies of any of the omitted annexes and schedules upon request by the SEC.

SIGNATURES